Ranexa (ranolazine extended-release tablets) for the treatment of chronic angina does not depend upon reductions in heart rate or blood pressure http://www.ranexa.com/wir_indications.html
  spacer  
spacer
 
right header
Ranexa provides antianginal and anti-ischemic effects that do not depend upon reductions in heart rate or blood pressure
 

Add Ranexa

title right border
spacer spacer spacer
left border
Ranexa is indicated for the treatment of chronic angina. Because Ranexa prolongs the QT interval, it should be reserved for patients who have not achieved an adequate response with other antianginal drugs. Ranexa should be used in combination with amlodipine, beta-blockers, or nitrates. The effect on angina rate or exercise tolerance appeared to be smaller in women than men.

Read More right link arrow

spacer
spacer spacer spacer
left border
Back to top
spacer
 
 
yellow footer
CVT Logo This website is intended for
US Healthcare Professionals only